Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:21
  • preuzimanja u poslednjih 30 dana:9

Sadržaj

članak: 2 od 5  
Back povratak na rezultate
Uticaj znanja pacijenata o hipertenziji na kontrolu krvnog pritiska - u kvalitativnoj studiji
aHealth Center "Dr Janoš Hadži", Bačka Topola
bUniverzitet u Novom Sadu, Medicinski fakultet, Katedra za farmakologiju i toksikologiju

e-adresaolga.horvat@mf.uns.ac.rs
Projekat:
Interakcije ksenobiotika i uticaj na sisteme u biomedicini (MPNTR - 41012)
This study was supported by the Provincial Secretariat for Science and Technological Development, Autonomous Province of Vojvodina [grant number 142-451-2565/2019-02].

Ključne reči: antihipertenzivna terapija; znanje o antihipertenzivnoj terapiji; antihipertenzivni lekovi
Sažetak
Uvod: Hipertenzija je značajan faktor rizika za nastanak cerebrovaskularnog insulta i akutnog infarkta miokarda. Održavanje krvnog pritiska na odgovarajućem nivou pomaže u sprečavanju nastanka komplikacije. Cilj: Cilj ove studije je bio da se ispita uticaj znanje o hipertenziji i pratećih faktora na kontrolu krvnog pritiska kod vanbolničkih pacijenata sa hipertenzijom u opštini Bačka Topola, Republika Srbija. Metod: Studija je sprovedena u martu 2019. godine u službama opšte medicine Doma Zdravlja u opštini BačkaTopola, među pacijentima koji su posetili svog lekara i popunili anonimni upitnik. Upitnik je obuhvatao pitanja o socio-demografskim karakteristikama, o faktorima vezanih za antihipertenzivne lekove, kao i o znanju o hipertenziji. Rezultati: Prosečnastarost ispitanika je bila 62.9 ± 10.7 godina. Najčešće propisivani antihipertenzivni lekovi bili su ACE inhibitori 80,8%, zatim b-blokatori 46.8%, blokatori kalcijumskih kanala 22.6%, diuretici 21%, a fiksna kombinacija antihipertenziva korišćena je kod 4.8% pacijenata. Većina ispitanika sa adekvatnom znanjem imala je dobro kontrolisan krvni pritisak (91.4%), dok samo 37.1% ispitanika sa prosečnom znanjem je imala dobro kontrolisan krvni pritisak. Ostali faktori koji su najčešće povezani sa lošom kontrolom krvnog pritiska i znanja nižeg nivoa o hipertenziji bili su: starija starosna dob, ženski pol, niži stepen obrazovanja, ređa poseta izabranog lekara, pacijenti sa više od jednog antihipertenzivnog leka, pacijenti sa dužim trajanjem lečenja hipertenzije i pacijenti koji nisu imali doplatu na antihipertenzivne lekove. Zaključak: Rezultati studije ukazuju da znanje pacijenata o hipertenziji i pratećih faktora u vezi sa lečenjem hipertenzije ima važnu ulogu na održavanju krvnog pritiska na adekvatnom nivou. Stoga edukacija ima ključnu ulogu na utemeljivanju racionalne upotrebe antihipertenziva i lečenja hipertenzije.
Reference
Akoko, B.M., Fon, P.N., Ngu, R.C., Ngu, K.B. (2017) Knowledge about hypertension and compliance with therapy among hypertensive patients in the bamenda Health district of Cameroon: A cross-sectional study. Cardiology and Therapy, 6(1), 53-67
Aubert, L., Bovet, P., Gervasoni, J.P., Rwebogora, A., Waeber, B., Paccaud, F. (1998) Knowledge, attitudes, and practices on hypertension in a country in epidemiological transition. Hypertension, 31(5), 1136-1145
Belletti, D.A., Zacker, C., Wogen, J. (2010) Effect of cardiometabolic risk factors on hypertension management: A cross-sectional study among 28 physician practices in the United States. Cardiovascular Diabetology, 9(1), 7
Borzecki, A.M., Glickman, M.E., Kader, B., Berlowitz, D.R. (2006) The effect of age on hypertension control and management. American Journal of Hypertension, 19(5), 520-527
Dhungana, R.R., Pandey, A.R., Bista, B., Joshi, S., Devkota, S. (2016) Prevalence and associated factors of hypertension: A community-based cross-sectional study in municipalities of Kathmandu, Nepal. International Journal of Hypertension, Volume 2016
Egan, B.M., Zhao, Y., Axon, R.N. (2010) US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA, 303(20), 2043-2050
Jankowska-Polańska, B., Uchmanowicz, I., Dudek, K., Mazur, G. (2016) Relationship between patients' knowledge and medication adherence among patients with hypertension. Patient Preference and Adherence, Volume 10(10), 2437-2447
Kažić, T., Ostojić, M. (2011) Cardiovascular drugs: A manual for therapy. Beograd: Integra, 18-43
Lović, D., Stojanov, V., Jakovljević, B., Krotin, M., Jurišić, V., Đorđevic, D., Paunović, K., Zdravković, M., Simonović, D., Bastać, D., Lović, B. (2013) Prevalence of arterial hypertension in Serbia: PAHIS study. Journal of Hypertension, 31(11), 2151-2157
Lulebo, A.M., Mutombo, P.B., Mapatano, M.A., Mafuta, E.M., Kayembe, P.K., Ntumba, L.T., Mayindu, A.N., Coppieters, Y. (2015) Predictors of non-adherence to antihypertensive medication in Kinshasa, Democratic Republic of Congo: A cross-sectional study. BMC Research Notes, 8(1), 526-526
Malik, A., Yoshida, Y., Erkin, T., Salim, D., Hamajima, N. (2014) Hypertension-related knowledge, practice and drug adherence amond in patients of a hospitam in Samarkand. Nagoya J. Med. Sci, (76), 255-263
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Bohm, M. (2013) ESH/ESC Guidelines for the management of arterial hypertension: The Task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens, 31(7), 1281-1357
Marinković, M., Ilić, N., Đokić, D., Andrejević, V., Damjanović, G., Samardžić, G., Tufegdžić, S., Vučić-Janković, M. (2014) Prevalencija hipertenzije kod odraslih u Šumadiji - unakrsno istraživanje. Vojnosanitetski pregled, vol. 71, br. 3, str. 245-250
McAlister, F.A., Wilkins, K., Joffres, M., Leenen, F.H.H., Fodor, G., Gee, M., Tremblay, M.S., Walker, R., Johansen, H., Campbell, N. (2011) Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. Canadian Medical Association Journal, 183(9), 1007-1013
Ministry of Health of The Republic of Serbia, Institute of Public Health of Serbia Dr Milan Jovanović Batut (2007) Final Report and Basic Results of the 2006 Health Survey of the Republic of Serbia. Beograd, 56-848
Ministry of Health of The Republic of Serbia, Institute of Public Health of Serbia Dr Milan Jovanović Batut (2014) Results of the 2013 population Health survey of Serbia. Beograd, 24-96
Ministry of Health of The Republic of Serbia, Institute of Public Health of Serbia Dr Milan Jovanović Batut (2017) Final report and basic results of the 2016 health survey of the Republic of Serbia. Beograd, 417-437
Penno, G., Solini, A., Bonora, E., Fondelli, C., Orsi, E., Zerbini, G., Trevisan, R., Vedovato, M., Gruden, G., Laviola, L., Nicolucci, A., Pugliese, G. (2013) Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: The RIACE Italian multicentre study. Journal of Internal Medicine, 274(2), 176-191
Pérez, M.C.R., de León, A.C., Torres, R.M.M., Coello, S.D., Sánchez, J.J.A., Díaz, B.B., et al. (2012) Factors associated with knowledge and control of arterial hypertension in the Canary Islands. Rev Esp Cardiol, 65(3), 234-240
Perković, V., Huxley, R., Wu, Y., Prabhakaran, D., Macmahon, S. (2007) The burden of blood pressure-related disease: a neglected priority for global health. Hypertension, 50(6), 991-997
Petrović, V. (2017) Health status of the population of AP Vojvodina 2016. Institute of Public Health of Vojvodina, http://www.izjzv.org.rs/?lng=lat&cir=0&link=4-21
Saleem, F., Hassali, M.A., Shafie, A.A., Awad, A.G., Bashir, S. (2011) Association between knowledge and drug adherence in patients with hypertension in Quetta, Pakistan. Tropical Journal of Pharmaceutical Research, 10(2), 125-132
Snider, M., Nuzum, D., Veverka, A. (2008) Long-acting nifedipine in the management of the hypertensive patient. Vasc Health Risk Manag, December; 4(6), 1249-1257
Spruill, T.M. (2010) Chronic psychosocial stress and hypertension. Current Hypertension Reports, 12(1), 10-16
Susan, R., Anu, K., Achu, T., Soumya, G., Vijayakumar, K., Anish, T. (2012) Antihypertensive drug compliance acrossclinic and community settings, in Thiruvananthapuram, South India. Health Sci, 1(3), JS002A
Šipetić, T. (2011) Turnover and consumption of finished drugs for human use in the Republic of Serbia in 2010. Beograd: Agency for Medicines and Medical Devices of Serbia
WHO (2012) The pursuit of responsible use of medicines: Sharing and learning from country experiences technical report prepared for the ministers Summit on the benefits of responsible use of medicines: Setting policies for better and cost-effective Health Care
World Health Organization (2010) ICD-10: International statistical classification of diseases and related Health problems: Tenth revision. 2 nd ed., https://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf
World Health Organization (2012) World Health statistics 2012. Geneva: WHO, http://apps.who.int/iris/bitstream/10665/44844/ 1/9789241564441_eng.pdf
Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., Dagenais, G. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The heart outcomes prevention evaluation study investigators. N Engl J Med, Jan 20;342(3), 145-153
 

O članku

jezik rada: engleski
vrsta rada: originalan članak
DOI: 10.5937/hpimj2002942H
objavljen u SCIndeksu: 18.09.2020.
Creative Commons License 4.0